跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 119 条关于
“Zhongmei Huadong”
全部
119
临床试验
49
药物
33
机构
15
资讯
22
2年前
HUADONG MEDICINE Reports Positive Phase I Results for Oral GLP-1 Receptor Agonist HDM1002
去年
Qyuns Therapeutics' Ustekinumab Biosimilar Approved in China for Psoriasis Treatment
去年
Senaparib Approved in China for First-Line Maintenance Therapy in Ovarian Cancer
去年
Vcare Partners with Huadong Medicine for VC005 JAK1 Inhibitor Commercialization in China
11个月前
Chance Pharma Partners with Huadong Medicine for CXG87 Asthma Treatment in China
21天前
Heidelberg Pharma and Huadong Medicine Expand Partnership to Co-Develop Next-Generation Antibody Drug Conjugates
去年
Huadong Medicine's ROR1-Targeting ADC HDM2005 Shows Promising Phase I Results in Relapsed Lymphomas
23天前
Heidelberg Pharma and Huadong Medicine Receive NMPA Approval for Phase Ib/II Trial of BCMA-Targeting ADC HDP-101 in Multiple Myeloma
9个月前
Heidelberg Pharma Appoints Dr. Dongzhou Jeffery Liu as New CEO Amid Leadership Transition
9个月前
CARsgen's CAR-T Therapy Zevor-Cel Gains Coverage Under China's New Commercial Health Insurance Catalogue
第 1 页,共 3 页
上一页
下一页